P2Y12 platelet inhibitor: Class Overview and Comparison
Quick answer: P2Y12 platelet inhibitor are a class of medicines used for specific therapeutic indications. iMedic covers 4 p2y12 platelet inhibitor substances. Below is a comparison table linking to detailed pages for each.
P2Y12 platelet inhibitor on iMedic (4 substances)
| Substance | Primary indications | Mechanism | Common dose |
|---|---|---|---|
| Brilique | Acute coronary syndrome, Secondary prevention after myocardial infarction | Brand name for ticagrelor; reversible direct-acting P2Y12 ADP receptor antagonis | 180 mg loading then 90 mg twice daily (60 mg twice daily for long-term) |
| Kengrexal | Percutaneous coronary intervention adjunct, Prevention of periprocedural thrombotic events | Intravenous reversible P2Y12 ADP receptor antagonist that inhibits platelet aggr | 30 mcg/kg IV bolus followed by 4 mcg/kg/min infusion |
| Prasugrel | Acute coronary syndrome, Prevention of atherothrombotic events post-PCI | Irreversibly inhibits the platelet P2Y12 ADP receptor preventing platelet aggreg | 60 mg loading dose, then 10 mg once daily |
| Prasugrel Eql Pharma | Acute coronary syndrome, Prevention of atherothrombotic events post-PCI | Irreversibly inhibits the platelet P2Y12 ADP receptor preventing platelet aggreg | 60 mg loading dose, then 10 mg once daily |
About P2Y12 platelet inhibitor
P2Y12 platelet inhibitor share a common mechanism of action and clinical use. Specific dosing, side effects, contraindications, and drug interactions vary between individual substances within the class. Click any substance above for full prescribing information and patient guidance.
Common considerations across the class
- Indication-specific selection: Different members may be preferred for different conditions or patient populations
- Dose equivalence: Members of the same class are not always interchangeable on a 1:1 dose basis
- Drug interactions: Class members often share interaction profiles (e.g., CYP enzyme effects) but individual variation matters
- Side effects: Some side effects are class-wide; others are substance-specific
- Contraindications: Individual contraindications may not generalize across the class
Always consult the prescribing information for the specific medicine prescribed and discuss with your clinician.
Frequently asked questions
What are P2Y12 platelet inhibitor?
P2Y12 platelet inhibitor are medicines that share a common mechanism of action used for specific therapeutic indications. iMedic currently covers 4 substances in this class with detailed pages for each.
Are all P2Y12 platelet inhibitor interchangeable?
No. While medicines in the same class share a mechanism, they differ in potency, dosing, drug interactions, and tolerability. Switching between them is a clinical decision based on individual response, side effects, and treatment goals.
How do I choose between different P2Y12 platelet inhibitor?
Selection depends on the specific clinical indication, patient factors (age, comorbidities, kidney/liver function, other medications), tolerability of side effects, cost, and clinician preference. This is a prescribing decision.
Are P2Y12 platelet inhibitor available as generics?
Most well-established class members are available as generic alternatives, often substantially less expensive than brand-name versions while clinically equivalent. Newer members may still be brand-only.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.